The company said members of its executive management team will take part in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, at 3:45 p.m. (PT). January 10, 2025

8-KRegulation FD DisclosureFiled Jan 10, 2025Period of report Jan 10, 2025Summary published (UTC) Oct 17, 2026

Key points

AI summary

The company said members of its executive management team will take part in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, at 3:45 p.m. (PT). January 10, 2025
Labcorp said a live audio webcast of the fireside chat will be available on its Investor Relations website at ir.Labcorp.com and will be archived for replay.
The company said it filed this 8-K under Item 7.01, Regulation FD Disclosure, and furnished its press release dated January 10, 2025 as Exhibit 99.1.
The company said in its press release that it has more than 60,000 employees who support clients in over 100 countries. It also said it contributed to over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Labcorp to Attend J.P. Morgan Healthcare Conference Fireside Chat

The company said members of its executive management team will take part in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, at 3:45 p.m. (PT). January 10, 2025

Source · Based on the filing body and exhibits

Live Audio Webcast Available and Archived for Replay

Labcorp said a live audio webcast of the fireside chat will be available on its Investor Relations website at ir.Labcorp.com and will be archived for replay.

Source · Based on the filing body and exhibits

Filing Type: Item 7.01, Regulation FD Disclosure

The company said it filed this 8-K under Item 7.01, Regulation FD Disclosure, and furnished its press release dated January 10, 2025 as Exhibit 99.1.

Source · Based on the filing body and exhibits

Company Overview: Employee Base and Testing Volume

The company said in its press release that it has more than 60,000 employees who support clients in over 100 countries. It also said it contributed to over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.